Carol A. Miller

14.5k total citations · 4 hit papers
66 papers, 5.0k citations indexed

About

Carol A. Miller is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Carol A. Miller has authored 66 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 12 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Carol A. Miller's work include Alzheimer's disease research and treatments (24 papers), Neuroscience and Neuropharmacology Research (8 papers) and Dementia and Cognitive Impairment Research (7 papers). Carol A. Miller is often cited by papers focused on Alzheimer's disease research and treatments (24 papers), Neuroscience and Neuropharmacology Research (8 papers) and Dementia and Cognitive Impairment Research (7 papers). Carol A. Miller collaborates with scholars based in United States, Australia and Canada. Carol A. Miller's co-authors include David R. Hinton, Alfredo A. Sadun, Janet C. Blanks, Berislav V. Zloković, Jorge Ghiso, James R. Bading, Miguel Calero, Shinya Yamada, Blas Frangione and David M. Holtzman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Carol A. Miller

61 papers receiving 4.8k citations

Hit Papers

Clearance of Alzheimer’s ... 1986 2026 1999 2012 2000 1986 2010 2017 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol A. Miller United States 28 2.4k 1.3k 1.1k 976 849 66 5.0k
Achim Berthele Germany 45 1.2k 0.5× 1.3k 1.0× 840 0.8× 314 0.3× 796 0.9× 178 7.7k
Femke H. Bouwman Netherlands 48 3.2k 1.3× 1.1k 0.8× 1.2k 1.1× 615 0.6× 1.2k 1.4× 158 6.8k
Xiaoyan Sun United States 33 2.4k 1.0× 1.3k 1.0× 593 0.6× 209 0.2× 268 0.3× 86 4.1k
Claire Paquet France 34 1.8k 0.8× 1.0k 0.8× 707 0.7× 223 0.2× 260 0.3× 177 4.4k
Claudio Mariani Italy 37 1.3k 0.6× 741 0.6× 923 0.9× 157 0.2× 377 0.4× 125 4.3k
Christian Humpel Austria 43 2.2k 0.9× 2.4k 1.8× 1.5k 1.4× 164 0.2× 306 0.4× 222 7.0k
Geidy E. Serrano United States 45 2.6k 1.1× 1.8k 1.4× 1.7k 1.5× 158 0.2× 265 0.3× 177 6.5k
Gerald D. Silverberg United States 38 1.5k 0.6× 997 0.8× 730 0.7× 124 0.1× 357 0.4× 105 5.4k
Agostino Baruzzi Italy 47 801 0.3× 2.2k 1.7× 957 0.9× 230 0.2× 216 0.3× 200 7.2k
C. Dirk Keene United States 46 2.5k 1.0× 3.0k 2.3× 2.0k 1.8× 168 0.2× 400 0.5× 234 8.5k

Countries citing papers authored by Carol A. Miller

Since Specialization
Citations

This map shows the geographic impact of Carol A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Miller more than expected).

Fields of papers citing papers by Carol A. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Miller. The network helps show where Carol A. Miller may publish in the future.

Co-authorship network of co-authors of Carol A. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Miller. A scholar is included among the top collaborators of Carol A. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Miller. Carol A. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Ruifang, et al.. (2023). Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19. Cancers. 15(14). 3598–3598. 3 indexed citations
2.
Dahl, Martin J., Mara Mather, Markus Werkle‐Bergner, et al.. (2021). Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease. Neurobiology of Aging. 112. 39–54. 69 indexed citations
3.
Bilousova, Tina, Carol A. Miller, Wayne W. Poon, et al.. (2015). Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. American Journal Of Pathology. 186(1). 185–198. 89 indexed citations
4.
Sokolow, Sophie, Karabi Nandy, Carol A. Miller, et al.. (2011). Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex. Neurobiology of Disease. 45(1). 381–387. 73 indexed citations
5.
Miller, Carol A.. (2008). Communication Difficulties in Hospitalized Older Adults with Dementia. AJN American Journal of Nursing. 108(3). 58–66. 43 indexed citations
6.
Liu, Yuanbin, et al.. (2004). Detecting bioactive amyloid β peptide species in Alzheimer's disease. Journal of Neurochemistry. 91(3). 648–656. 10 indexed citations
7.
Kubo, Takekazu, Yoshihiro Kumagae, Carol A. Miller, & Isao Kaneko. (2003). β-Amyloid Racemized at the Ser26Residue in the Brains of Patients with Alzheimer Disease: Implications in the Pathogenesis of Alzheimer Disease. Journal of Neuropathology & Experimental Neurology. 62(3). 248–259. 63 indexed citations
8.
Miller, Carol A.. (2003). Safe medication practices. Geriatric Nursing. 24(5). 314–317. 36 indexed citations
9.
Miller, Carol A.. (2002). Anticholinergics: The good and the bad. Geriatric Nursing. 23(5). 286–287. 4 indexed citations
10.
Bading, James R., Shinya Yamada, Jasmina B. Mačkić, et al.. (2002). Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid Angiopathy. Journal of drug targeting. 10(4). 359–368. 72 indexed citations
11.
Miller, Carol A.. (2000). Report from the World Alzheimer Congress 2000. Geriatric Nursing. 21(5). 274–275. 6 indexed citations
12.
Miller, Carol A.. (2000). Update on drugs for emotional pain in elders. Geriatric Nursing. 21(3). 164–165. 1 indexed citations
13.
Miller, Carol A.. (1999). Drug/Food/Food Supplements Interactions. Geriatric Nursing. 20(3). 164–168. 2 indexed citations
14.
Zhou, Lulu, et al.. (1998). Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration. Annals of Neurology. 44(1). 99–109. 84 indexed citations
15.
Miller, Carol A.. (1994). The physiologic effects of air transport on the neonate.. PubMed. 13(7). 7–10. 5 indexed citations
16.
Waters, Cheryl & Carol A. Miller. (1994). Autosomal dominant Lewy body parkinsonism in a four‐generation family. Annals of Neurology. 35(1). 59–64. 100 indexed citations
17.
Backstrom, Jon R., Carol A. Miller, & Zoltán A. Tökés. (1992). Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the Hippocampus. Journal of Neurochemistry. 58(3). 983–992. 96 indexed citations
18.
Kalivas, Peter W., et al.. (1989). The acute histopathology of MPTP in the mouse CNS. Brain Research Bulletin. 23(1-2). 1–17. 39 indexed citations
19.
Blanks, Janet C., David R. Hinton, Alfredo A. Sadun, & Carol A. Miller. (1989). Retinal ganglion cell degeneration in Alzheimer's disease. Brain Research. 501(2). 364–372. 228 indexed citations
20.
Miller, Carol A., Ira Shulman, & Clive R. Taylor. (1981). Demyelination with hemophagocytic lymphohistiocytosis of the CNS. Acta Neuropathologica. 54(2). 153–155. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026